Für diesen Artikel ist leider kein Bild verfügbar.

Holland–Frei Cancer Medicine, 9th Edition

RC Bast (Autor)

Software / Digital Media
2008 Seiten
2017
Wiley-Blackwell (Hersteller)
978-1-119-00082-2 (ISBN)
297,50 inkl. MwSt
  • Keine Verlagsinformationen verfügbar
  • Artikel merken
Holland-Frei Cancer Medicine, Ninth Edition, offers a balanced view of the most current knowledge of cancer science and clinical oncology practice. This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients.


A translational perspective throughout, integrating cancer biology with cancer management providing an in depth understanding of the disease
An emphasis on multidisciplinary, research-driven patient care to improve outcomes and optimal use of all appropriate therapies
Cutting-edge coverage of personalized cancer care, including molecular diagnostics and therapeutics
Concise, readable, clinically relevant text with algorithms, guidelines and insight into the use of both conventional and novel drugs
Includes free access to the Wiley Digital Edition providing search across the book, the full reference list with web links, illustrations and photographs, and post-publication updates

Robert C. Bast Jr, MD, Vice President for Translational Research, MD Anderson Cancer Center, Houston, TX, USA Carlo M. Croce, MD, Distinguished University Professor, The John W. Wolfe Chair in Human Cancer Genetics, Professor and Chair, Department of Molecular Virology, Immunology and Medical Genetics, The Wexner Medical Center, The Ohio State University, Columbus, OH, USA William Hait, MD, PhD, Global Head research and Development, Janssen pharmaceutical companies of Johnson and Johnson, NJ, USA Waun Ki Hong, MD, DMSc, Professor of Thoracic/Head and Neck Medical Oncology, American Cancer Society Professor, Samsung Distinguished University Chair in Cancer Medicine Emeritus, The University of Texas M.D.Anderson Cancer Center, Houston, TX, USA Donald W. Kufe, MD, Distinguished Physician, Dana-Farber Cancer Institute, Professor of Medicine Harvard Medical School, Leader, Translational Pharmacology and Early Therapeutic Trials Program Dana-Farber/Harvard Cancer Center, Boston, MA, USA Martine Piccart-Gebhart MD PhD, Professor of Oncology, Universite Libre de Bruxelles (ULB), Head of the Medicine Department, Jules Bordet Institute, Brussels, Belgium Raphael E. Pollock, MD, PhD, FACS, Professor and Director, Division of Surgical Oncology, Surgeon in Chief, James Comprehensive Cancer Center, Surgeon in Chief, The Ohio State University Health System, The Ohio State University Wexner Medical Center, Columbus, OH, USA Ralph R. Weichselbaum, MD, Daniel K. Ludwig Professor Chair Dept of Radiology and Cellular Oncology University of Chicago Hospital Director Chicago Tumor Institute, IL, USA Dr Hongyang Wang, Professor and Director, National Center for Liver Cancer, China; and Eastern Hepatobiliary Surgery Hospital, Shanghai, China James F. Holland, MD, ScD (hc), Distinguished Professor of Neoplastic Diseases, Director Emeritus of Derald H.Rutttenberg Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA ASSOCIATE EDITOR Fadlo R. Khuri, MD, Executive Associate Dean for Research, Emory University School of Medicine, Atlanta, GA, USA; President, the American University of Beirut, Beirut, Lebanon

Erscheint lt. Verlag 1.3.2017
Verlagsort Hoboken
Sprache englisch
Maße 150 x 250 mm
Gewicht 666 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-119-00082-3 / 1119000823
ISBN-13 978-1-119-00082-2 / 9781119000822
Zustand Neuware
Haben Sie eine Frage zum Produkt?